Literature DB >> 29778358

Applying the 2017 McDonald diagnostic criteria for multiple sclerosis.

Philipp Schwenkenbecher1, Ulrich Wurster1, Kurt-Wolfram Sühs1, Martin Stangel1, Thomas Skripuletz2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29778358     DOI： 10.1016/S1474-4422(18)30160-1

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  6 in total

Review 1.  Misdiagnosis of multiple sclerosis: Impact of the 2017 McDonald criteria on clinical practice.

Authors:  Andrew J Solomon; Robert T Naismith; Anne H Cross
Journal:  Neurology       Date:  2018-10-31       Impact factor: 9.910

Review 2.  The Influence of Renal Function Impairment on Kappa Free Light Chains in Cerebrospinal Fluid.

Authors:  Franz F Konen; Philipp Schwenkenbecher; Ulrich Wurster; Konstantin F Jendretzky; Nora Möhn; Stefan Gingele; Kurt-Wolfram Sühs; Malte J Hannich; Matthias Grothe; Torsten Witte; Martin Stangel; Marie Süße; Thomas Skripuletz
Journal:  J Cent Nerv Syst Dis       Date:  2021-11-19

3.  Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort study.

Authors:  Stefan Bittner; Falk Steffen; Timo Uphaus; Muthuraman Muthuraman; Vinzenz Fleischer; Anke Salmen; Felix Luessi; Achim Berthele; Luisa Klotz; Sven G Meuth; Antonios Bayas; Friedemann Paul; Hans-Peter Hartung; Ralf Linker; Christoph Heesen; Martin Stangel; Brigitte Wildemann; Florian Then Bergh; Björn Tackenberg; Tania Kuempfel; Frank Weber; Uwe K Zettl; Ulf Ziemann; Hayrettin Tumani; Sergiu Groppa; Mark Mühlau; Carsten Lukas; Bernhard Hemmer; Heinz Wiendl; Ralf Gold; Frauke Zipp
Journal:  EBioMedicine       Date:  2020-05-24       Impact factor: 8.143

4.  The Impact of Immunomodulatory Treatment on Kappa Free Light Chains as Biomarker in Neuroinflammation.

Authors:  Franz Felix Konen; Ulrich Wurster; Torsten Witte; Konstantin Fritz Jendretzky; Stefan Gingele; Hayrettin Tumani; Kurt-Wolfram Sühs; Martin Stangel; Philipp Schwenkenbecher; Thomas Skripuletz
Journal:  Cells       Date:  2020-03-31       Impact factor: 6.600

Review 5.  The Immunological Therapeutic Strategies for Controlling Multiple Sclerosis: Considerations during the COVID-19 Pandemic.

Authors:  Maryam Azimzadeh; Nora Möhn; Sajjad Ghane Ezabadi; Zahra Moghimi Esfandabadi; Alireza Soleimani; Elaheh Ranjbar; Maliheh Jahromi; Reihaneh Seyedebrahimi; Thomas Skripuletz; Farshad Moharrami Kasmaie
Journal:  Biomolecules       Date:  2021-09-17

6.  Decreased Intrathecal Concentrations of Free Light Chains Kappa in Multiple Sclerosis Patients Taking Very High Effective Disease-Modifying Treatment.

Authors:  Marie Süße; Franz Felix Konen; Philipp Schwenkenbecher; Kathrin Budde; Matthias Nauck; Matthias Grothe; Malte Johannes Hannich; Thomas Skripuletz
Journal:  Diagnostics (Basel)       Date:  2022-03-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.